On the recordApril 19, 2023
The FDA is holding an advisory committee meeting on opiates today in particular on the questionable clinical trial practice known as enriched enrollment.
Source
congress.govThe FDA is holding an advisory committee meeting on opiates today in particular on the questionable clinical trial practice known as enriched enrollment.
Manchin discusses an FDA meeting addressing concerns about clinical trial practices.
Share & report
More from Joe Manchin
Mr. President, first of all, let me thank my dear friend Senator Carper, who heads up EPW and does a tremendous job with his staff. We have had a great working relationship here. We all know that having a fully staffed FERC is going to…
They better figure out how they lost moderate, centrist, fiscally responsible, socially compassionate.
Mr. President, I spoke at some length about the important work of the Federal Energy Regulatory Commission yesterday. I spoke also about the statutory requirement that the Commission members be able ``to assess fairly the needs and…